Search Results 111-120 of 17286 for hba1c

  1. A Study to Evaluate the Impact on NASH with Fibrosis of Obeticholic Acid Treatment - Mayo Clinic

    HbA1c > 9.5% within 60 days before Day 1. Evidence of other forms of known chronic liver disease including: Positive test result at Screening for hepatitis ...

  2. Vocal Biomarker Of Gastroesophageal Reflux - Mayo Clinic

    Poorly controlled diabetes (HbA1c > 7.5%). Active tobacco use. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated ...

  3. Health and Wellness Coaching for Employees with T2D - Mayo Clinic

    an uninterrupted hemoglobin HbA1c ≥ 6.5% within a year despite standard care;; BMI of 25 or above (recorded or to be calculated) in the EMR;; have a T2D ...

  4. INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) - Mayo Clinic

    HbA1c ≥ 8%;; NOTE: HbA1c is not a required screening lab; however, if HbA1C is performed at screening, result must be < 8%. NOTE: If patient's HbA1c is ≥ 8 ...

  5. A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients with Chronic Ulcers - Mayo Clinic

    ... HbA1c < 6.5% - Satisfactory blood supply to the wound verified by the measurement of the oxygen level of the foot tissue (TCPO2 > 30mmHg) in patients with ...

  6. Safety And Efficacy Of Selonsertib, GS-0976, GS-9674, And Combinations In Participants With Bridging Fibrosis Or Compensated Cirrhosis Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    HbA1c ≤ 9.5%; Alanine aminotransferase (ALT) < 5 x Upper Limits of Normal (ULN); Platelet count ≥ 125,000/μL. Exclusion Criteria: Prior history of ...

  7. Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - Mayo Clinic

    Poorly controlled diabetes mellitus defined as having a HbA1c ≥8.5% (ie, ≥69.5 mmol/mol) or estimated HbA1c based on fructosamine if HbA1c is not evaluable ( ...

  8. A Study To Evaluate The Effectiveness And Safety Of Relacorilant - Mayo Clinic

    Has severe, uncontrolled hypertension (mean SBP > 170 mm Hg or mean DBP > 110 mm Hg at Screening), based on 24-hour ABPM. · Has poorly controlled DM (HbA1c > 12% ...

  9. A Pivotal Study Of The Premia Spine TOPS™ System - Mayo Clinic

    Insulin-dependent diabetes mellitus (unless well-controlled defined as HbA1c < 7%). HbA1c value must be within 3 months of screening. Immunologically ...

  10. DAYBREAK: Phase 2 Study In Patients With Specific Gene Defects In The MC4R Pathway - Mayo Clinic

    Glycated hemoglobin (HbA1C) >10.0% at Screening. History of significant liver disease other than non-alcoholic fatty liver disease (NAFLD) or nonalcoholic ...